LanceSoft, Inc. ยท 1 day ago
Scientist
LanceSoft, Inc. is seeking a Scientist to join the Systems Immunology Lab within the Pharmaceuticals Inflammation & Immunology Research Unit. The successful candidate will generate large-scale single-cell perturbational datasets using functional genomics and single-cell transcriptomics technologies, working collaboratively within a small, multidisciplinary team.
Responsibilities
Generate and customize lentiviral libraries for functional genomics studies
Maintain extensive cell culture systems, including primary immune cells and cell lines
Produce edited cell pools using lentiviral transduction and arrayed electroporation
Develop, modify, and optimize protocols across diverse cell types and large-scale applications
Generate and process single-cell data using commercial platforms, including 10x Genomics
Support multiple research projects in collaboration with cross-functional experimental teams
Qualification
Required
Bachelor's or Master's degree in Biology, Immunology, or a related scientific field
3+ years of relevant hands-on laboratory experience
3+ years of experience with standard cell culture techniques
Hands-on experience with primary immune cell isolation, handling, and stimulation
Proficiency in molecular biology techniques, including: Lentiviral infection, qPCR, Western blotting, Flow cytometry
Preferred
Experience with pooled CRISPR screening in immune cells
Hands-on exposure to CRISPRi, CRISPRa, or other in vitro gene-editing technologies
Company
LanceSoft, Inc.
Established in 2000, LanceSoft is a pioneer in delivering top-notch Global Workforce Solutions and IT Services to a diverse clientele.
H1B Sponsorship
LanceSoft, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (55)
2024 (32)
2023 (23)
2022 (25)
2021 (60)
2020 (80)
Funding
Current Stage
Late StageCompany data provided by crunchbase